The interleukin-1 receptor antagonist anakinra improves first-phase insulin secretion and insulinogenic index in subjects with impaired glucose tolerance-Reference-Cited by-同舟云学术

The interleukin-1 receptor antagonist anakinra improves first-phase insulin secretion and insulinogenic index in subjects with impaired glucose tolerance

Published:2014-08-13 Issue:12 Volume:16 Page:1269-1273
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

van Poppel P. C. M.¹,van Asseldonk E. J. P.¹,Holst J. J.²,Vilsbøll T.³,Netea M. G.¹⁴,Tack C. J.⁵

Affiliation:

1. Department of Internal Medicine; Radboud University Nijmegen Medical Centre; Nijmegen the Netherlands

2. Department of Biomedical Sciences; Panum Institute University of Copenhagen; Copenhagen Denmark

3. Department of Medicine; Copenhagen University Hospital; Copenhagen Denmark

4. Nijmegen Institute for Infection; Inflammation and Immunity (N4i); Nijmegen the Netherlands

5. Department of Internal Medicine (463); Radboud University Medical Center; Nijmegen the Netherlands

Funder

European Foundation for the Study of Diabetes

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/dom.12357/fullpdf

Reference12 articles.

1. Contributions of insulin-resistance and insulin-secretory defects to the pathogenesis of type 2 diabetes mellitus;Gerich;Mayo Clin Proc,2003

2. Progressive loss of beta-cell function leads to worsening glucose tolerance in first-degree relatives of subjects with type 2 diabetes;Cnop;Diabetes Care,2007

3. U.K. prospective diabetes study 16. Overview of 6 years' therapy of type II diabetes: a progressive disease. U.K. Prospective Diabetes Study Group;Diabetes,1995

4. Cytokines and beta-cell biology: from concept to clinical translation;Donath;Endocr Rev,2008

5. Glucose-induced beta cell production of IL-1beta contributes to glucotoxicity in human pancreatic islets;Maedler;J Clin Invest,2002

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Normoglycemia and physiological cortisone level maintain glucose homeostasis in a pancreas-liver microphysiological system;Communications Biology;2024-07-18

2. Molecular and pathophysiological relationship between obesity and chronic inflammation in the manifestation of metabolic dysfunctions and their inflammation‑mediating treatment options (Review);Molecular Medicine Reports;2024-04-09

3. Type 2 diabetes mellitus: Novel targets and multitarget-directed phytotherapy;Antidiabetic Medicinal Plants;2024

4. Immunomodulatory therapy in diabetes mellitus: A pharmacological approach;Biochemical Immunology of Diabetes and Associated Complications;2024

5. Diabetes mellitus: Classification, mediators, and complications; A gate to identify potential targets for the development of new effective treatments;Biomedicine & Pharmacotherapy;2023-12